The sector is at a unique, even revolutionary moment in time: already developing world-class, cutting-edge therapeutics in areas like oncology and gene therapy, and getting a boost from a variety of new policies and regulatory factors, its creator says.

from MarketWatch.com - Top Stories https://ift.tt/2OEvV70
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2OEvV70
via IFTTT
Kommentare
Kommentar veröffentlichen